The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Interesting comments about US approval route https://www.usatoday.com/story/news/health/2023/02/08/covid-antiviral-interferon-lambda-shot/11199875002/
https://news.yahoo.com/experimental-covid-treatment-could-promising-220001007.html
https://twitter.com/fdadeviceinfo/status/1458459394392330242?s=21
Just came across this, anyone else aware of this Korean company, with a US arm?
http://m.koreaherald.com/view.php?ud=20210923000744
RNS out
I must admit that is causing me some head scratching too, Matterhorn. As a LTH I am constantly reassessing risk/reward against timescales that we are fed. To be fair to the company, this is in line with their issued info and interview comments but it does cause confusion potentially. I shall revert to company issued info I think and not place too much credence on 3rd party sites until it becomes more clear.
Came across this https://www.isrctn.com/ISRCTN85436698 with updated editorial notes at the bottom (changes made 20/07/21). These dates are not yet reflected on the NIH but appear to push into November 21. Very specific dates as opposed to the estimates on https://www.clinicaltrials.gov/ct2/show/NCT04732949
https://www.globenewswire.com/news-release/2021/07/15/2263510/0/en/Early-Results-of-BetterLife-Preclinical-Study-Showing-AP-003-rhIFNa2b-has-Similar-Potent-Efficacy-Against-Different-Variants-of-COVID-19.html
Early stage inhaled interferon trials - more evidence of their importance.....
4 cases in London and 8 in the UK recorded
https://www.mylondon.news/news/health/london-covid-cases-contagious-new-20991581
Suggests that post July 19th there will still be 17 million unprotected in the population....
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)01589-0/fulltext
https://www.youtube.com/watch?v=brLQBARijn0
Proactive news 2 hrs ago - compassionate use granted